Navigera till Andra Kryptovalutor

INCYIncyte Corporation

Snabblänkar

Positionsberäknare

Positionsstorlek (USD)Hävstång

Krav på marginal

$10.00

P&L om INCY rör sig

+1%+$10.00

+5%+$50.00

+10%+$100.00

Börja handla med {leverage}x hävstång

Incyte Corporation

INCY

$97.07

+0.00% (24h)

AktierNivå C1000x hävstång

Viktiga punkter

Senast uppdaterad:: 2026-06-08

•Incyte betalar 1,25 miljarder dollar för Vega Therapeutics, med målet att diversifiera sig från sin JAK-hämmarintäktskoncentration genom att fokusera på sällsynta blödningssjukdomar.
•Affärens stadium (preklinisk vs. Fas 2+) är den viktigaste variabeln – mer avslöjad klinisk data kommer direkt att driva om INCY omvärderas uppåt eller nedåt.
•INCY handlas för närvarande till 97,07 dollar; förvänta dig förhöjd implicit volatilitet när säljsidan-analytiker reviderar uppskattningar för resultat per aktie och FoU-utgifter.
•SMID-cap-bolag inom hematologi och sällsynta sjukdomar är indirekta gynnade när M&A-golvvärderingar bekräftas.
•Denna affär validerar Star Therapeutics inkubator-modell och kan påskynda riskkapitalinvesteringar i liknande plattformsdrivna bioteknik-skapande strategier.

Pris & Marknadsstruktur

Laddar diagram...

Handelsregimstatus

Hävstång

1000x

(Max på CoinUnited.io)

Volatilitet

N/A

Glossary

Key listed-stock and CFD terms, one line each — so the page is unambiguous for both readers and AI answer engines.

Stock CFD	A contract for difference on a share price — price exposure only, not ownership of the underlying shares.
Extended hours	Pre-market and after-hours trading outside the exchange’s regular session.
Basis risk	The risk that the CFD reference price and the exchange execution price do not move in step.
P/E	Price-to-earnings ratio = share price ÷ earnings per share; a common valuation gauge.
Gross margin	Gross profit ÷ revenue; reflects product-level profitability.
EPS	Earnings per share = net income ÷ diluted shares outstanding.

Senaste pulser

2026-06-08AktierVolatil

INCY

Incyte förvärvar Vega Therapeutics för 1,25 miljarder dollar – Hematologi-satsning fördjupar vågen av bioteknik-M&A

Incyte Corporation (NASDAQ: INCY) har meddelat förvärvet av Vega Therapeutics, ett privatägt bioteknikbolag fokuserat på hematologi som utvecklats inom Star Therapeutics företagsbyggnadsplattform, för

2026-06-07AktierVolatil

INCY

Incytes ~$2 miljardars stjärnterapeutikaffär: Hävstångsscenarier & Läsning av bioteknik-M&A

Som rapporterats av Financial Times närmar sig Incyte Corporation (INCY) en affär värderad till cirka 2 miljarder dollar för att förvärva Star Therapeutics, en privat läkemedelsutvecklare för blodsjuk

Visa alla INCY pulser

Get Started with Incyte Corporation

Start trading Incyte Corporation on CoinUnited.io with industry-leading leverage and zero fees.

Trade with Leverage

Trade INCY CFDs with up to 1000x leverage on CoinUnited.io.

Up to 1000x leverage
Zero trading fees
Advanced risk management tools

Trade INCY Now

Explore Stocks

Browse the full stocks market on CoinUnited.io with 125+ instruments.

125+ stocks instruments
Real-time market data
Professional charting tools

Browse Stocks

Learn Stocks Trading

Read our in-depth research and analysis on stocks markets.

Expert market analysis
Technical analysis basics
Daily market insights

Read Our Research

How to Trade Incyte Corporation: Step-by-Step Guide

Learn how to trade Incyte Corporation (INCY) on CoinUnited.io with up to 1000x leverageand zero trading fees. Follow this simple step-by-step guide to start CFD trading today.

Create Your CoinUnited.io Account

✓Quick and free registration
✓Email and password setup
✓Two-factor authentication for security

Verify Your Identity

Complete the KYC verification process to unlock full trading features and higher limits.

✓Upload government-issued ID
✓Proof of address document
✓Usually verified within minutes

Deposit Funds

Fund your account using one of the supported deposit methods.

Deposit Methods

•Cryptocurrency deposits (BTC, ETH, USDT)
•Bank transfer available
•No minimum deposit requirement

Find INCY in the Stocks Section

Navigate to the stocks market section and search for INCY. You can trade Incyte Corporation as a CFD with up to 1000x leverage.

✓Search for "INCY" in the trading platform
✓Select CFD trading mode
✓Review the current price and market data

Place Your Trade

Choose your position direction (long or short), set your leverage, and enter your position size to trade Incyte Corporation.

✓Long (buy) if you expect INCY to rise
✓Short (sell) if you expect INCY to fall
✓Set stop-loss and take-profit levels

Monitor & Manage Risk

Keep track of your open positions and manage risk with stop-loss orders and position sizing.

✓Monitor P&L in real-time
✓Adjust stop-loss as needed
✓Never risk more than you can afford to lose

Order Types

Market Order

Execute immediately at the current market price. Best for quick entries.

Limit Order

Set a specific price to enter. The order fills only when the market reaches your price.

Stop-Loss Order

Automatically close your position at a specified price to limit potential losses.

Important Tips

• Start with a small position to understand how leverage works
• Always set a stop-loss to protect your capital
• Higher leverage amplifies both gains and losses
• Never invest more than you can afford to lose

Redo att handla Incyte Corporation?

Upp till 1000x hävstång

Börja handla INCY

symbol

INCY

Marknader

Aktier

Sektor

General

CU-produktkod

INCY

Taggar

Enterprise Strategic Partnership WaveEnterprise Partnership Deal RepricingPost War Energy Tech Partnership SurgeMulti Jurisdiction Crypto Regulatory TighteningBtc Dividend Reinvestment ETF WaveBlackstone Apollo AI Pharma Energy DealsCrypto Exchange Acquisition WaveDEFI Fintech Product Launch WaveCrypto Media Regulatory EnforcementGlobal Crypto Equity Regulation Wave

Similar Stocks Assets

Explore other stocks instruments in the same sector as Incyte Corporation. Compare performance and find trading opportunities.

Tempus AI, Inc

$61.31

▲24.1%

Estee Lauder

$98.08

▲16.2%

Hecla Mining Company

$20.55

▲14.5%

Coeur Mining, Inc.

$20.91

▲12.8%

Kinross Gold Corporation

$29.93

▲10.3%

View all General →

Om Författaren

CoinUnited.io Research Team

This Incyte Corporation page is compiled by CoinUnited.io's research team: analysts covering listed equities and global markets, working from primary filings and named third-party data rather than opinion.

Vår Forskningsmetodik

Every figure is traced to a primary or named third-party source and dated: financial statements from the company’s SEC filings, institutional ownership from Form 13F, analyst targets from aggregated third-party coverage, and market data from the CoinUnited reference price. The Source Map on this page lists each one with its source and the date we last checked it.

Disclaimer: content is for informational and educational purposes only and is not personalized financial advice. A stock CFD carries significant risk and provides price exposure only, not equity ownership. Always conduct your own research and consult a qualified financial advisor.

Ansvarsfriskrivningar & Referenser

Viktig riskvarning

A CoinUnited stock CFD gives price exposure to Incyte Corporation only, not equity ownership: no shareholder voting rights, no dividends, and no settlement in the underlying share.

Leverage magnifies losses as well as gains, and a position can be liquidated long before the underlying share price recovers. The underlying listing trades on exchange hours, so the reference price can gap between sessions.

Användare bör göra egen research och rådgöra med kvalificerade finansiella experter innan några investeringsbeslut fattas. Skaparna och operatörerna av denna plattform tar inget ansvar för eventuella finansiella förluster eller andra skador som kan uppstå vid förlitande på den givna informationen.

Leveraged trading is extremely risky and you may lose your entire deposit.

Metodöversikt

Figures on this page are compiled from primary and named third-party sources, not produced by a forecasting model. Each one carries its source and date in the Source Map above.

Financial statements: the company’s own SEC filings (10-K / 10-Q), read from XBRL
Market data: the CoinUnited reference price and daily closes
Institutional ownership: SEC Form 13F quarterly filings
Analyst targets: aggregated third-party sell-side coverage — third-party opinion, not CoinUnited’s view
Peer multiples: third-party trailing-twelve-month ratios

CoinUnited does not publish a price forecast or target for Incyte Corporation.

Senaste metodologiöversyn:

Redo att börja handla Incyte Corporation?

Gå med i tusentals handlare och börja din Incyte Corporation handelsresa idag. Få tillgång till avancerade handelsverktyg och konkurrenskraftiga avgifter.

Handla INCY/USDT Registrera dig nu